Study of nirgundi and hadjod base formulation on knee joint ostioarthritis
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecified
- Registration Number
- CTRI/2022/07/043798
- Lead Sponsor
- CSIR NEW DELHI HCP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Volunteers with affected joints,who are willing to undergo the treatment.
Age between 40 -70 years.
Individuals who are willing and able to participate for 6 months of duration.
Patients not willing for trial.
Patients below the age of 40 years and above 70 years.
Patients who have participated in any clinical trial during past 6 months.
Subjects with cardiac problems.
Subjects with uncontrolled diabetes mellitus
Subjects with multiple joint disorders.
Subjects with advanced rheumatoid arthritis.
Subject advanced knee osteoarthritis.
Subjects suffering from major systemic illness necessitating long term drug treatment (R.A, PTB, malignancy etc.)
Any other condition which the Investigator thinks may compromise the safety of the subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement will be evaluated by objective evaluation of knee joints (affected joint or both joints) (mandatory); X-ray and MRI depending upon availability. It will be done to check the efficacy of the productOSTEOARTHRITIS PATIENT. <br/ ><br>EFFECT ON CHOLEGEN HEALTHTimepoint: 8 WEEKS
- Secondary Outcome Measures
Name Time Method Other parameters such as Complete Blood Count, ESR, Liver function test, renal function test etc will be evaluated to check safety and any adverse effect on the patient.Timepoint: 8 WEEKS